NO2010019I1 - 6-per-deoksy-6-per-(2-karboksyl)tio-y-cyklodextrin - Google Patents

6-per-deoksy-6-per-(2-karboksyl)tio-y-cyklodextrin

Info

Publication number
NO2010019I1
NO2010019I1 NO2010019C NO2010019C NO2010019I1 NO 2010019 I1 NO2010019 I1 NO 2010019I1 NO 2010019 C NO2010019 C NO 2010019C NO 2010019 C NO2010019 C NO 2010019C NO 2010019 I1 NO2010019 I1 NO 2010019I1
Authority
NO
Norway
Prior art keywords
per
deoxy
cyclodextrin
thio
carboxyl
Prior art date
Application number
NO2010019C
Other languages
English (en)
Other versions
NO2010019I2 (no
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8241767&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2010019(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon Nv filed Critical Organon Nv
Publication of NO2010019I1 publication Critical patent/NO2010019I1/no
Publication of NO2010019I2 publication Critical patent/NO2010019I2/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO2010019C 1999-11-29 2010-11-10 6-per-deoksy-6-per-(2-karboksetyl)tio-y-cyklodextrin NO2010019I2 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99309558 1999-11-29
PCT/EP2000/011789 WO2001040316A1 (en) 1999-11-29 2000-11-23 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block

Publications (2)

Publication Number Publication Date
NO2010019I1 true NO2010019I1 (no) 2010-11-22
NO2010019I2 NO2010019I2 (no) 2012-08-27

Family

ID=8241767

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20022522A NO328790B1 (no) 1999-11-29 2002-05-28 6-merkapto-cyklodekstrinderivater og anvendelse derav samt sett og farmasoytisk preparat
NO2010019C NO2010019I2 (no) 1999-11-29 2010-11-10 6-per-deoksy-6-per-(2-karboksetyl)tio-y-cyklodextrin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20022522A NO328790B1 (no) 1999-11-29 2002-05-28 6-merkapto-cyklodekstrinderivater og anvendelse derav samt sett og farmasoytisk preparat

Country Status (34)

Country Link
US (3) USRE44733E1 (no)
EP (1) EP1259550B1 (no)
JP (2) JP3880041B2 (no)
KR (1) KR100716524B1 (no)
CN (1) CN1188428C (no)
AR (1) AR026605A1 (no)
AT (1) ATE288450T1 (no)
AU (1) AU776536B2 (no)
BE (1) BE2008C047I2 (no)
BR (1) BRPI0015947B8 (no)
CA (1) CA2390463C (no)
CO (1) CO5251450A1 (no)
CY (1) CY2008018I1 (no)
CZ (1) CZ298206B6 (no)
DE (2) DE122008000068I2 (no)
DK (1) DK1259550T3 (no)
ES (1) ES2237496T3 (no)
FR (1) FR08C0052I2 (no)
HK (1) HK1049489A1 (no)
HU (1) HU227451B1 (no)
IL (1) IL149423A0 (no)
LU (1) LU91501I2 (no)
MX (1) MXPA02004940A (no)
NL (1) NL300356I2 (no)
NO (2) NO328790B1 (no)
NZ (1) NZ518752A (no)
PE (1) PE20010902A1 (no)
PL (1) PL203012B1 (no)
PT (1) PT1259550E (no)
RU (1) RU2260013C2 (no)
SK (1) SK286282B6 (no)
TW (1) TWI242015B (no)
WO (1) WO2001040316A1 (no)
ZA (1) ZA200203538B (no)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6744471B1 (en) * 1997-12-05 2004-06-01 Olympus Optical Co., Ltd Electronic camera that synthesizes two images taken under different exposures
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
ES2269504T3 (es) * 2000-11-02 2007-04-01 Akzo Nobel N.V. Uso de agentes complejantes con cortisol en cuadros de tratamimento de transtornos relacionados con hipercortisolemia.
CA2543443A1 (en) 2003-10-31 2005-05-12 The University Of Kansas Sulfoalkyl ether-alkyl ether cyclodextrin derivatives
JP2007538112A (ja) 2004-01-29 2007-12-27 ピナクル ファーマシューティカルズ β−シクロデキストリン誘導体およびそれらの炭疽致死毒に対する使用
DK3520779T3 (da) 2004-04-23 2022-03-21 Cydex Pharmaceuticals Inc DPI formulering indeholdende sulfoalkylethercyclodextrin
AU2006211173A1 (en) 2005-01-28 2006-08-10 Pinnacle Pharmaceuticals, Inc. Beta-cyclodextrin derivatives as antibacterial agents
BRPI0520654B8 (pt) 2005-10-26 2021-05-25 Cydex Pharmaceuticals Inc composições de sulfoalquil éter ciclodextrina e processo para preparação das mesmas
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20090069412A1 (en) * 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched sugammadex
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
US7938283B2 (en) * 2008-06-20 2011-05-10 Grainpro, Inc. System and method for hermetic storage of agricultural commodities during shipping
WO2010053487A1 (en) 2008-11-07 2010-05-14 Cydex Pharmaceuticals, Inc. Composition containing sulfoalkyl ether cyclodextrin and latanoprost
CN101591402B (zh) * 2009-05-05 2011-11-30 杭州奥默医药技术有限公司 6-脱氧砜类环糊精衍生物及其制备方法
US8492538B1 (en) 2009-06-04 2013-07-23 Jose R. Matos Cyclodextrin derivative salts
DE102010012281A1 (de) * 2010-03-22 2011-09-22 Fresenius Medical Care Deutschland Gmbh Pharmazeutische Zusammensetzungen enthaltend substituiertes 6-Deoxy-6-sulfanylcyclodextrin
CN101864003B (zh) * 2010-06-11 2012-05-02 漆又毛 一种6-脱氧硫醚氨基酸环糊精衍生物的合成方法
PL2609120T3 (pl) * 2010-08-25 2016-03-31 Davuluri Ramamohan Rao Ulepszony sposób wytwarzania sugammadeksu
CN102060941B (zh) 2010-11-26 2012-12-26 漆又毛 6-脱氧α-氨基酸衍生物环糊精及制备和应用
DK3702374T3 (da) 2012-02-15 2022-06-27 Cydex Pharmaceuticals Inc Fremsgangsmåde til fremstilling for cyclodextrin-derivater
RU2615385C2 (ru) 2012-02-28 2017-04-04 Сидекс Фармасьютикалс, Инк. Композиции алкилированного циклодекстрина и способы их получения и применения
JP5892847B2 (ja) * 2012-04-27 2016-03-23 Ｄｏｗａホールディングス株式会社 シクロデキストリンとシリカ含有物質との複合材料、及びその製造方法、並びにガス吸着剤
GB201211153D0 (en) * 2012-06-22 2012-08-08 Farmhispania Pharmaceutical compositions
EP2909239A4 (en) 2012-10-22 2016-06-08 Cydex Pharmaceuticals Inc ALKYLATED CYCLODEXTRIN COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF
EP2956486B1 (en) * 2013-02-14 2020-09-30 Neuland Laboratories Ltd An improved process for preparation of sugammadex sodium
WO2015179963A1 (en) 2014-05-29 2015-12-03 Uti Limited Partnership Cyclodextrin-based polyanionic and non-ionic dendrimers
AU2014398349B2 (en) 2014-06-26 2020-08-06 Maruishi Pharmaceutical Co., Ltd. Rocuronium preparation with improved stability
CN105348412B (zh) * 2014-08-22 2018-06-05 江苏恩华药业股份有限公司 一种舒更葡糖钠的纯化方法
PT3183295T (pt) 2014-08-22 2023-11-03 Cydex Pharmaceuticals Inc Composições de ciclodextrina alquilada fracionada e processos para preparação e utilização das mesmas
EP3939582A1 (en) 2015-03-19 2022-01-19 Cydex Pharmaceuticals, Inc. Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same
CN104844732B (zh) * 2015-03-27 2017-05-03 山东滨州智源生物科技有限公司 一种舒更葡糖钠的制备方法
AU2015390471A1 (en) * 2015-04-08 2017-11-09 John KLASSEN Pharmaceutical compositions of polyanionic and non-ionic cyclodextrin-based dendrimers and uses thereof
EP3303413A4 (en) * 2015-05-29 2019-02-06 Alaparthi, Lakshmi Prasad PROCESSES FOR THE PREPARATION OF SUGAMMADEX AND ITS INTERMEDIATES
CN104922693A (zh) * 2015-06-19 2015-09-23 南开大学 一种阴离子型环糊精与抗癌药物包合物及制备方法
CA3001200A1 (en) * 2015-10-07 2017-04-13 Uti Limited Partnership Multifunctional polyanionic cyclodextrin dendrimers
AU2016359420B2 (en) * 2015-11-25 2020-10-01 Fresenius Kabi Ipsum S.R.L. An improved process for the preparation of sugammadex and its intermediates
AU2016359431B2 (en) * 2015-11-25 2020-10-22 Fresenius Kabi Ipsum S.R.L. Crystalline forms of per-chloro-gamma-cyclodextrines
EP3433285B1 (en) * 2016-03-22 2020-06-03 Fresenius Kabi iPSUM S.r.l. An improved process for the preparation of sugammadex
EP3448395B1 (en) * 2016-04-29 2020-04-22 Alveron Pharma B.V. Cyclodextrins as procoagulants
WO2017144734A2 (en) 2016-06-23 2017-08-31 Synthon B.V. Process for making sugammadex
US10526422B2 (en) 2016-06-29 2020-01-07 Beijing Creatron Institute Of Pharmaceutical Research Co., Ltd. Process for preparation and purification of Sugammades sodium
WO2017084401A1 (zh) 2016-06-29 2017-05-26 北京睿创康泰医药研究院有限公司 舒更葡糖钠的制备及纯化方法
CN107778383B (zh) 2016-08-24 2020-03-10 王炳永 一种舒更葡糖钠的精制方法
US10385142B2 (en) 2017-01-23 2019-08-20 Scinopharm Taiwan, Ltd. Method for preparing sugammadex sodium
KR20190141244A (ko) 2017-05-03 2019-12-23 사이덱스 파마슈티칼스, 인크. 사이클로덱스트린 및 부설판을 함유하는 조성물
CN109021148B (zh) * 2017-06-08 2020-11-10 天津科伦药物研究有限公司 一种制备舒更葡糖钠的方法
US10442871B2 (en) * 2017-06-22 2019-10-15 Lawrence Livermore National Security, Llc Modified cyclodextrins for the selective sequestration of fentanyl related compounds and uses thereof
ES2761899T3 (es) 2017-06-30 2020-05-21 Synthon Bv Proceso para preparar Sugammadex
US10233263B1 (en) * 2017-08-23 2019-03-19 Formosa Laboratories, Inc. Method for preparation of sugammadex sodium
TWI703163B (zh) * 2017-08-23 2020-09-01 台耀化學股份有限公司 舒更葡糖鈉之製備方法及其晶型
US11104746B2 (en) 2017-11-27 2021-08-31 Medichem, S.A. Process for the synthesis of a cyclodextrin derivative
CN107892727B (zh) * 2017-11-27 2019-12-24 合肥博思科创医药科技有限公司 一种舒更葡糖钠的纯化方法
US11225565B2 (en) 2018-04-06 2022-01-18 Synthon B.V. Purification of sugammadex
KR102054228B1 (ko) * 2018-05-28 2019-12-10 연성정밀화학(주) 슈가마덱스 나트륨염의 제조방법
US11634511B2 (en) 2018-06-07 2023-04-25 Merck Sharp & Dohme Llc Processes for the preparation of sugammadex
CN110615860A (zh) * 2018-06-20 2019-12-27 江苏恒瑞医药股份有限公司 一种舒更葡糖钠的纯化方法
WO2020028448A1 (en) 2018-08-02 2020-02-06 Pliva Hrvatska D.O.O. Solid state forms of sugammadex sodium
US11845811B2 (en) 2018-09-20 2023-12-19 Natco Pharma Limited Process for the preparation of Sugammadex sodium and its novel polymorphic form
CA3112872A1 (en) 2018-09-27 2020-04-02 Werthenstein Biopharma Gmbh Novel crystalline forms of sugammadex
JP6950966B2 (ja) * 2018-11-01 2021-10-13 丸石製薬株式会社 スガマデクス又はその薬理学的に許容される塩含有液剤及びその製造方法
CN109824800A (zh) * 2018-12-29 2019-05-31 鼎元(天津)生物医药科技有限公司 一种选择性肌松拮抗药舒更葡萄糖钠的制备方法
CN109438591B (zh) * 2018-12-29 2021-02-09 博瑞生物医药（苏州）股份有限公司 舒更葡糖钠的制备工艺
US20220169753A1 (en) 2019-03-29 2022-06-02 Hospira, Inc. An improved process for preparation of sugammadex acid and sugammadex sodium
CN111978435B (zh) 2019-05-22 2021-05-25 合肥博思科创医药科技有限公司 一种高纯度舒更葡糖钠的制备方法
US11324692B2 (en) 2019-07-03 2022-05-10 Galenicum Health S.L.U. Method to prepare pharmaceutical compositions of suggamadex
US20220273517A1 (en) 2019-08-30 2022-09-01 Terumo Kabushiki Kaisha Injection formulation
RU2724900C1 (ru) * 2019-10-24 2020-06-26 Маруиси Фармасьютикал Ко., Лтд. Препарат рокурония с улучшенной стабильностью
CN111019016B (zh) * 2019-12-27 2022-02-18 武汉嘉诺康医药技术有限公司 一种舒更葡糖钠杂质的合成方法
WO2021170304A1 (en) 2020-02-28 2021-09-02 Medichem, S.A. Method for drying sugammadex
CN111714459B (zh) * 2020-06-18 2022-06-14 广州瑞尔医药科技有限公司 一种注射用舒更葡糖钠粉针剂及其制备方法
US11097023B1 (en) 2020-07-02 2021-08-24 Par Pharmaceutical, Inc. Pre-filled syringe containing sugammadex
EP3932391A1 (en) 2020-07-03 2022-01-05 Galenicum Health S.L.U. Method to prepare pharmaceutical compositions
US11446325B2 (en) * 2020-09-30 2022-09-20 Cyclolab Cyclodextrin Research And Development Laboratory Ltd. Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases
US11945788B2 (en) 2021-06-07 2024-04-02 Nuray Chemicals Private Limited Process for preparing pitolisant hydrochloride and solid-state forms thereof
CN113637097A (zh) * 2021-08-10 2021-11-12 北京恒创星远医药科技有限公司 6-全脱氧-6-全碘代-γ-环糊精晶体及其制备方法和应用
CN115708777A (zh) 2021-08-19 2023-02-24 北京费森尤斯卡比医药有限公司 包含巯基环糊精衍生物或其可药用盐的包装药品和保存方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929813A (en) 1973-12-26 1975-12-30 Interx Research Corp Novel pro-drug derivatives of pyridinium aldoxime type cholinesterase reactivators and process for preparing same
JPS52108027A (en) 1976-03-09 1977-09-10 Rikagaku Kenkyusho Anticarcinogen
US4816462A (en) 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
HU194858B (en) 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
IT1196033B (it) 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
GB8506792D0 (en) 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
GB8613688D0 (en) 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0819004B2 (ja) 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
HU201783B (en) 1987-10-13 1990-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing partially methylized carboxy-acyl-beta-cyclodextrines and salts
US5002935A (en) 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5017566A (en) 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
DK0465535T3 (da) 1989-04-03 1999-03-01 Janssen Pharmaceutica Nv Regioselektive substitutioner i cyclodextriner
US5173481A (en) 1989-04-03 1992-12-22 The United States Of America As Represented By The Department Of Health And Human Services Preparation of specifically substituted cyclodextrins
DK0447171T3 (da) * 1990-03-15 1994-12-12 Tanabe Seiyaku Co Polysulfat af cyclodextrinderivat og fremgangsmåde til fremstilling deraf
US5180716A (en) * 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
JP2556236B2 (ja) 1991-08-29 1996-11-20 田辺製薬株式会社 β−シクロデキストリン誘導体のポリ硫酸エステル及びその製法
US5840881A (en) 1992-11-27 1998-11-24 Takeda Chemical Industries, Ltd. Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility
US5767112A (en) 1994-10-21 1998-06-16 Poli Industria Chimica, S.P.A. Muscle relaxant pharmaceutical compositions
AU708107B2 (en) 1994-11-04 1999-07-29 Commonwealth Scientific And Industrial Research Organisation Method for treating animals
GB2307176A (en) * 1995-11-15 1997-05-21 Todd Selwyn Everest Anti-inflammatory clathrating agents for topical use
US5935941A (en) 1997-10-24 1999-08-10 Pitha; Josef Alkylations of cyclodextrins leading to derivatives which have a ridgidly extended cavity
US5834446A (en) * 1996-06-21 1998-11-10 Queen's University At Kingston Nerve process growth modulators
JP4249282B2 (ja) 1998-02-27 2009-04-02 日本食品化工株式会社 新規シクロデキストリン誘導体及びその製造方法
WO1999060987A2 (en) 1998-05-29 1999-12-02 Neurosciences Research Foundation, Inc. Control of pain with endogenous cannabinoids
JP4782334B2 (ja) 1999-08-13 2011-09-28 ナームローゼ・フエンノートチヤツプ・オルガノン 薬物起因性神経筋遮断のための拮抗薬としての化学的キレート化剤の使用
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
US20020111377A1 (en) 2000-12-22 2002-08-15 Albany College Of Pharmacy Transdermal delivery of cannabinoids
CA2437851C (en) 2001-02-14 2011-05-17 Akzo Nobel Nv 2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
TW200402417A (en) 2002-06-21 2004-02-16 Akzo Nobel Nv 1-[(Indol-3-yl)carbonyl]piperazine derivatives

Also Published As

Publication number Publication date
HUP0203755A3 (en) 2003-10-28
NZ518752A (en) 2003-03-28
CA2390463A1 (en) 2001-06-07
NL300356I1 (nl) 2008-10-01
EP1259550B1 (en) 2005-02-02
NL300356I2 (nl) 2009-04-01
FR08C0052I2 (fr) 2009-12-18
AU5438001A (en) 2001-06-12
CY2008018I2 (el) 2009-11-04
HK1049489A1 (en) 2003-05-16
CY2008018I1 (el) 2009-11-04
JP3880041B2 (ja) 2007-02-14
NO2010019I2 (no) 2012-08-27
IL149423A0 (en) 2002-11-10
DE122008000068I1 (de) 2009-04-23
USRE44733E1 (en) 2014-01-28
AR026605A1 (es) 2003-02-19
LU91501I9 (no) 2019-01-02
US6949527B2 (en) 2005-09-27
DE122008000068I2 (de) 2011-06-16
MXPA02004940A (es) 2003-05-23
CZ20021814A3 (cs) 2002-08-14
CN1188428C (zh) 2005-02-09
DE60017947D1 (de) 2005-03-10
CA2390463C (en) 2009-02-03
NO328790B1 (no) 2010-05-18
US20040029833A1 (en) 2004-02-12
BRPI0015947A (pt) 2002-08-20
KR100716524B1 (ko) 2007-05-10
DE60017947T2 (de) 2005-06-23
ZA200203538B (en) 2003-08-04
NO20022522L (no) 2002-05-28
PL203012B1 (pl) 2009-08-31
BRPI0015947B1 (pt) 2012-02-07
ES2237496T3 (es) 2005-08-01
CO5251450A1 (es) 2003-02-28
WO2001040316A1 (en) 2001-06-07
NO20022522D0 (no) 2002-05-28
JP2006348301A (ja) 2006-12-28
HUP0203755A2 (hu) 2003-04-28
HU227451B1 (en) 2011-06-28
KR20020063900A (ko) 2002-08-05
SK7262002A3 (en) 2002-11-06
ATE288450T1 (de) 2005-02-15
CZ298206B6 (cs) 2007-07-18
AU776536B2 (en) 2004-09-16
JP2003515623A (ja) 2003-05-07
PE20010902A1 (es) 2001-09-06
SK286282B6 (sk) 2008-06-06
TWI242015B (en) 2005-10-21
LU91501I2 (fr) 2009-01-26
JP4563972B2 (ja) 2010-10-20
PL356097A1 (en) 2004-06-14
EP1259550A1 (en) 2002-11-27
FR08C0052I1 (no) 2009-02-27
DK1259550T3 (da) 2005-04-25
PT1259550E (pt) 2005-05-31
RU2260013C2 (ru) 2005-09-10
CN1402737A (zh) 2003-03-12
BE2008C047I2 (no) 2019-12-11
US6670340B1 (en) 2003-12-30
BRPI0015947B8 (pt) 2021-07-06

Similar Documents

Publication Publication Date Title
NO2010019I1 (no) 6-per-deoksy-6-per-(2-karboksyl)tio-y-cyklodextrin
DE50010505D1 (de) Gurtaufrollersystem
DE122007000064I2 (de) Erythropoietinkonjugate
DE19983871T1 (de) Fönvorrichtung
DE50002834D1 (de) Handstempel
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
DE50009570D1 (de) Wechselcorrugator
DE50007953D1 (de) Beleuchtungsanordung
DE50008613D1 (de) Sicherungsring
DE50000805D1 (de) Aufsitzspanner
DE50006899D1 (de) Antistatikum
FI19992631A (fi) Radiaalimäntähydraulimoottori
DE10085008T1 (de) Oberflächenbehandlungsdüse
DE50012482D1 (de) Tibiamarknagel
DE50003660D1 (de) Diacylhydrazinderivate
DE50003259D1 (de) Textilie
DE50006013D1 (de) Anschlagpuffer
DE19983890T1 (de) Ventiltaktgebungsjustiereinrichtung
DE50001640D1 (de) Nahfeldoptische untersuchungsvorrichtung
DE50008429D1 (de) Kraftstofffraktioniereinrichtung
DE50006759D1 (de) Piperidinalkohole
DE50009208D1 (de) Hydroxyphenylvinylthiazole
DE50006829D1 (de) Benzoylpyridazine
ATA121799A (de) Ausbeulgerät
DE50003283D1 (de) Exzenterspannzwinge